CBIO
Price:
$0.5113
Market Cap:
$1.02B
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammator...[Read more]
Industry
Biotechnology
IPO Date
2006-04-12
Stock Exchange
NASDAQ
Ticker
CBIO
Dividends are a key part of long-term returns for investors, and Catalyst Biosciences, Inc. (CBIO) has a track record worth reviewing. Looking at dividend history for CBIO gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2023-01-13
Dividend Yield
0%
Annual Dividend
$0.02
P/E Ratio
-0.02
Payout Ratio
0
Dividend per Share
$0
EPS
-20.70
Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
---|---|---|---|---|
2023-01-13 | $0.016 | $0.24 | 2022-12-26 | |
2022-09-21 | $0.3626 | $1.43 | 2022-09-20 | 2022-08-25 |
2015-08-20 | $0.1443 | $59.76576 | 2015-08-19 | 2015-08-18 |
The table below shows Catalyst Biosciences, Inc. (CBIO) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Catalyst Biosciences, Inc. (CBIO) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Check out the dividend history of other popular stocks:
Stock name | Dividend yield |
---|---|
Bellerophon Therapeutics, Inc. (BLPH) | 1.58% |
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Catalyst Biosciences, Inc. (CBIO) without the pain and hassle of copy pasting data.
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is CBIO’s dividend yield?
What is the difference between regular and special dividends?
Has CBIO increased its dividends over time?
Why might dividend history data be delayed?
How often does CBIO pay dividends?
What factors impact CBIO's dividend payments?
Can dividends change over time?
What is CBIO’s next dividend date?